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Participation of a  thymus humoral factor (THF)  1 in  the induction of im- 
mune reactivity has  been demonstrated in  the  last  few years. Thus,  partial 
recovery of  cell-mediated  and  humoral  immune  reactions  were  observed in 
thymectomized mice implanted with thymus tissue contained in cell-imperme- 
able chambers (1-4). It was subsequently demonstrated that administration of 
extracts  from  thymus  tissue  prepared  from  different  species  to  neonatally 
thymectomized (NTx) mice partially restores their ability to produce an im- 
mune response to sheep red blood cells (5, 6), as well as to reject skin and tu- 
mor allografts (7). Furthermore, spleen cells from NTx mice gained the capacity 
to elicit an in vitro graft-vs.-host (GvH)response  when incubated inTHF prepa- 
rations (8). The above observations prompted us to investigate the biochemical 
mechanisms by which THF confers immunological reactivity upon noncompe- 
tent lymphoid cell populations in the hope that this will provide insight into the 
pathways  leading to maturation of lymphoid cells.  Since recent work in our 
laboratory suggested that THF selectively activates thymus-derived (T) cell 
population  (9-11,  footnote 2),  it was of interest to  follow specific metabolic 
changes occurring in this cell population. 
The in vitro GvH test (12) was used as an assay to evaluate the induction by 
THF of immunological maturation in spleen cells from NTx mice. Previous re- 
sults obtained using this system suggested that lymphoid cells gain competence 
following brief  exposure  to  THF  (13),  thus  indicating  possible  membranal 
changes. Therefore, activation of membranal enzymes in lymphoid cells exposed 
to THF were also studied. 
A preliminary report of this investigation has been presented elsewhere (14). 
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Materials and Methods 
Mice.--C57BL/6 and  (C3H/eb X  C57BL/6)F1 hybrids were used in most of the experi- 
ments.  Thymectomy was performed within  24  h  after  birth  by  a  modification of Miller's 
technique (15). Animals found to contain a thymic remnant were discarded from the experi- 
ments. In some experiments, adult thymectomized (Balb X  C57BL/6)F1 hybrid female mice 
were used. 
Preparation of Cdl Suspensions.--Spleens  were removed aseptically from 6- to 8-wk old 
intact or neonatally thymectomized C57BL/6 or from intact (C3H/eb X  C57BL/6)F1 mice. 
Thymuses were obtained from 6- to 8-wk old C57BL/6 animals. Both sexes were equally used 
as donors. The organs removed were dispersed by pressure through a stainless steel mesh into 
organ culture medium (O.C.M.)  (Eagle's basal medium, supplemented with 10% Difco horse 
serum [Difco Laboratories, Detroit, Mich.] and 5% chick embryo extract), or Eagle's basal 
medium (E.M.). The cells were further dissociated by means of a syringe with 27 gauge needle. 
Erythrocytes were removed from spleen cell suspensions  by washing the cells in 0.83% solu- 
tion of NH4C1 pH 7. Allquots of cells were stained with Turk's solution and nucleated cells 
were  counted  in  a  hemacytometer.  Exclusion  of 0.05%  trypan  blue  solution  was  used  as 
a  measure  of  viability.  To  obtain  bone  marrow-derived  and  thymus-derived  spleen  cells 
(Balb X  C57BL/6)F1 hybrid female mice 2-mo old were thymectomized, irradiated  (750 R 
and injected within 1 h intravenous with 30 X  108 syngeneic bone marrow cells or 100 >(  106 
syngeneic thymus cells.  7 days later their spleens were removed and these spleen cell popula- 
tions were considered as B and T cells, respectively (16). 
Preparation of Extracts.--Partially  purified calf thymus and spleen extracts were used in 
this investigation. The extracts were prepared  as previously described  (13),  and  stored  at 
--  10°C at a concentration of 1 mg protein/ml of 0.005 M Na Phosphate buffer pH 7.4. Chemi- 
cal analysis  revealed the presence  of small amounts  of RNA but no DNA in  the  thymus 
preparation.  In contrast  with proteolytic digestion,  treatment  of the  thymus  extract with 
RNase did not abolish its activity (Kook and Trainin, unpublished observations). Thus the 
concentration of active material used in the present experiment is expressed as protein per 
milliliter. In experiments where the activity of THF was compared to that of controls, either 
equal amounts of spleen extract protein or equal volumes of phosphate buffer were added to 
control samples. 
Materials Tested.--In  addition to THF and spleen extracts (SE), the following substances 
were tested for their capacity to activate spleen cell populations: polyadenylic-uridylic acid 
(Poly[A: U]), double strand, physiological salt (P-L Biochemicals Inc., Milwaukee, Wis.); the- 
ophylline,  (theophylline)s. ethylenediamine (Sigma Chemical Co., St. Louis, Mo.); dibutyril 
cAMP  (D-B  cAMP), N s, O2~-dibutyril  adenosine 3 ~  , 5Ccyclic monophosphoric  acid,  mono- 
sodium salt,  (Sigma); prostaglandin  E2(PGE2)  and flufenamic acid  [N-(ot,a,a-trifluoro-m- 
tolyl)  anthranilic  acid]  were kindly donated  by  Dr.  U. Zor,  Department  of Biodynamics, 
Weizmann Institute of Science,  Rehovot, Israel. 
Test o/Immunocompetence In Vitro.--Immunocompetence  of spleen cells was evaluated by 
the ability of cell suspensions  from NTx C57BL/6 mice compared to cell suspensions  from 
(C3H/eb  X  C57BL/6)FI mice to induce enlargement of C3H/eb  X  C57BL/6)F1 newborn 
spleen explants, according to the in vitro method developed by Auerbach and Globerson (12). 
As described previously (8), cultures were considered reactive when the index of splenomegaly 
obtained was 1.2 or more after the 4th day of the test. 
Induction of Competence  in Spleen Cdls.--Exposure  of spleen cells to the different materials 
tested was carried out either by addition of the materials to the medium for the 4-day duration 
course of the GvH assay, or by incubation of spleen cell suspensions with the tested materials 
for 30 min before assay of immunocompetence. When preincubated, cell suspensions  consisting 
of 20-25 X  106 cells per ml of E.M. were used unless specified otherwise. The cells were then 
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cases the test materials were added at the specified concentrations.  As control to the test 
materials, equalvolumes of 0.005 M Na-phosphate buffer pH 7.4 were used. 
Measurement of Adenyl Cyclase Activity and Intracdlular  Levels of cAMP.--Adenyl cyclase 
activity was measured by the procedure of Krishna et al. (17), after incubation of spleen cells 
in E.M. for 1 h with thymus extract "(20 #g protein per ml), spleen extract (20 #g protein per 
ml), or equal volumes of 0.005 M Na-phosphate buffer pH 7.4. The assay is based on the con- 
version of exogenous [SH]ATP by membranous  adenyl cyclase to  [~HIcAMP. Theiabeled 
cAMP is then isolated by chromatography on Dowex 50-H  ~ columns followed by precipitation 
of all nucle0tides and inorganic phosphate by ZnSO4-Ba(OH)2. TMs treatment leaves cAMP 
in solution (17). The purity of the cAMP fractions obtained by this method was verified by the 
chromatographic procedures established by Krishna et al. (17). [3It]ATP sp act 19 Ci/mmol 
was obtained from Schwarz/Mann Div., Orangeburg,  N.Y. Dowex 50-It  + was obtained from 
Bio-Rad Laboratories, Richmond, Calif. 
Changes in intracellular levels of cAMP in thymus cells were measured  at different  time 
intervals after exposure to THF stimulation, or at one time point after incubation with in- 
creasing concentrations of THF. Intracellular cAMP levels were measured  by a slight mod- 
ification of Gilman's procedure (18), using the cAMP assay kit provided by The Radio-chemi- 
cal Centre, Amersham, England (code TRK.432). After incubation, the ceils were spun in the 
cold, boiled in  the  assay buffer,  and  homogenized  in a  homogenizer  with a motor-driven 
Teflon pestle using  a  total of 30 strokes.  Greater and consistent recoveries  of cAMP have 
been  demonstrated by the use of such procedure (19) than by precipitating the cells with 
TCA as suggested by Gilman (18). 
RESULTS 
In parallel to our findings on THF  activity (5,  8,  13),  it has been demon- 
strated that complexes of homoribopolymeres of Poly (A:U) can increase the 
immunological competence of lymphoid cells (20-24),  and restore the immune 
reactivity of spleen cells obtained from NTX  mice (25).  Previous experiments 
performed in our laboratory (26)  have shown  that  at relatively high  concen- 
trations Poly (A: U)  and polyadenylic acid did not restore the competence of 
~lymphoid cells obtained from NTx  mice to  induce  a  GvH  response in' vitro. 
Therefore, we decided to extend these experiments by testing a  range of rela- 
tively lower  concentrations  of  Poly  (A:U)  (22).  As  shown  in  Table  I,  Poly 
(A:U)  added to  the culture medium at  concentration  of 0.001/zg  per ml re- 
TABLE I 
Effect of Various Concentrations of Poly(A : U) on the Induction  of In Vitro GvH Response by 
Spleen Cells  from NTx C57BL/6 Mice 
Substance tested  Concm OZg/ml medium)  Incidence of reactive cultures  Culture response 
% 
--  --  o/s  0/5  0/5  0 
THF  20*  5/5  4/5  4/5  87 
Poly(A:U)  0.00016  0/5  0/5  0 
Poly(A:U)  0.001  4/5  3/4  4/5  79 
Poly(A:  U)  1  0/5  0/5  0 
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stores the competence of spleen cells taken from NTx mice to produce a  GvH 
response which is similar to the response conferred when 20/zg protein per ml 
THF is added to the medium (8, 13, 27). Relatively lower or higher concentra- 
tions of Poly (A:U) such as 0.00016/~g per ml or 1/~g per ml of incubation me- 
dium, respectively, were not effective. 
Since it has been shown that poly(A~ U) increases adenyl cyclase activity in 
mouse spleen cells (28), it was of interest to explore whether THF would also 
modify adenyl cyclase activity. Thus, the actRdty of this enzyme in lympho- 
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FzG. 1. The effect  of THF on adenyl cyclase  activity in spleen  cells from NTx and normal 
(N) C57BL/6 mice. SE was used as control. Cells were incubated in the presence of 20 
protein per ml of THF or SE for 1 h at 37°C in E.M. 
incubation of spleen cells from NTx or normal C57BL/6 mice in the presence of 
THF (20/~g protein per ml of E.M.) significantly increased adenyl cyclase ac- 
tivity in those cells,  compared to controls. It can be seen that calf spleen ex- 
tract prepared by a  procedure identical to that used for preparation of THF 
(8, 13) did not modify the activity of adenyl cyclase of spleen cells from either 
NTx or normal mice compared to that of controls (Fig. 1, exp. 2). It can also be 
observed from the results presented in Fig. 1 that THF restores the activity of 
adenyl cyclase in spleen cells of NTx mice to that of spleen cells obtained from 
normal mice. 
Since spleen cells from either normal or NTx mice contain bone marrow-de- 
rived, as well as thymus-derived lymphocytes (9, 29), it was of interest to de- 
termine whether or not the effect exerted by THF on the activity of adenyl 
cyclase in spleen cells is due to activation of the enzyme in both cell types. For ABRAHAM  I.  KOOK  AND  NATHAN  TRAININ  197 
that purpose 30 X 106 bone marrow cells or 100 X  10Lthymus cells from (Balb X 
C57BL/6)F1 donors were injected i.v. into adult thymectomized  and irradiated 
(750 R) syngeneic hosts. 7 days later the hosts spleen cells were obtained and 
were considered B  and T  cells,  respectively (16). These cell populations were 
incubated simultaneously for I h in the presence of THF under the same condi- 
tions  described in  the  experiments presented in  Fig.  1.  The level of adenyi 
cyclase activity in the cells was determined, and the results are shown in Fig. 2. 
In both experiments shown here, it can be noted that THF increased the level 
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FIG. 2.  The effect of THF on adenyl cyclase activity in spleen cells from adult (Balb X 
C57BL/6)F1 mice thymectomized,  irradiated (750 R) and reconstituted with syngeneic  bone 
marrow (B) or thymocytes (T). Cells were incubated in the presence  of 20/zg protein per ml 
of THF for 1 h at 37°C in E.M. 
the enzymatic activity was observed in bone marrow-derived spleen cells. Thus, 
it appears that the cell responding to THF stimulation is a "T" cell. 
The measurement of adenyl cyclase activity reported  in the  above  experi- 
ments is based on the conversion of exogenous [SH]ATP to [SH]cAMP  (17). It 
was of interest to investigate, in addition, the changes in endogenous cAMP in 
lymphocytes induced by THF, and to follow the time course of such a response. 
The above results indicated that the cells responding to THF are thymus-de- 
rived cells. Since thymus cells,  with respect to T  and B  cells,  represent a  ho- 
mogeneous lymphoid cell population  compared  to  spleen  cells,  thymus  cells 
from C57BL/6 mice were chosen for that purpose. 25  X  10  e cells were incu- 
J~ated with 50/zg of THF protein per ml of incubation medium. Control sus- 198  THYMUS  HUMORAL  FACTOR  AND  IMMUNE  COMPETENCE 
pensions of thymocytes were incubated with equal volumes of phosphate buffer. 
Changes in the intracellular levels of cAMP were measured at specified  time in- 
tervals. The results are shown in Fig. 3. It can be seen that cellular cAMP level 
increases  rapidly following incubation with  THF.  A  threefold increase  over 
control levels was observed within 2 rain, the earliest observation made. There- 
after,  intracellular  cAMP level gradually declined,  but was still  higher  than 
control level at 60 min.  Fig. 4  demonstrates  the changes in the intracellular 
level of cAMP in thymocytes after 5 min incubation with increasing concentra- 
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FIo. 3.  The effect of THF on intracellular levels of cAMP in thymocytes of C57BL/6 
mice. 50 X 106 cells were incubated in 2 ml of E.M. at 37°C. Incubation started by addition 
of 50 #g protein per ml of THF. (©--O), (El--El), THF present; (O--O), ~  THF 
absent; (A), (A) normal levels of cAMP. 
tions of THF. It can be seen that cAMP levels increase with higher concentra- 
tions of THF up to 200 #g protein per ml of THF. THF concentration of 300 #g 
protein per ml does not seem to induce any further increase in cellular cAMP 
levels.  However, only two determinations of cAMP levels  were made at this 
THF concentration and the variation obtained does not permit a definite con- 
clusion. Nevertheless, it can be observed that cA HP levels increase in a linear 
fashion with increasing concentrations of THF up to about 100 t~g protein per 
ml. Thereafter the curve begins to flatten,  indicating that a  maximum effect 
has been reached by THF under the present experimental conditions. 
To eliminate the possibility that the effects on the cellular levels of cAMP ob- ABRAHAM  I.  KOOK  AND  NATHAN  TRAININ  199" 
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Fro.  4.  The effect of increasing THF  concentrations on intracellular levels of cAMP in 
thymocytes of C57BL/6 mice. 50 X  106 cells were incubated in 2 ml of E.M. at 37°C for 5 
min. Incubation started by the addition of THF. The figure represents results of two experi- 
ments each done in duplicates. 
served with increasing concentration of THF are due to contaminating amounts 
of cAMP in the preparations, several THF preparations including those used in 
the above experiments were assayed for their cAMP contents. No cAMP could 
be demonstrated  even in volumes twice as concentrated as those used in  the 
above experiments. 
The observations that THF stimulates adenyl cyclase activity and induces a 
rapid rise in intracellular cAMP levels in lymphocytes bring forward the possi- 
bility that  these cellular changes are closely linked  to  the induction  of com- 
petence by THF. This implies that THF exerts its effect on lymphoid cell popu- 
lations by a  mechanism similar to  that  demonstrated for other hormones on 
their respective target tissues  (30).  This prompted us to investigate whether 
substances like D-B cAMP and theophylline which are known to modify intra- 
cellular cAMP levels would also influence the immunological behavior of non- 
competent lymphoid cell populations.  The effect of various concentrations  of 
D-B cAMP on the capacity of spleen cells from NTx mice to induce an in vitro 
GvH response was assayed. The results are shown in Table II. It can be  seen 
that D-B cAMP at concentration of 0.001  #g per ml incubation medium can be 
a  substitute for THF in the in vitro GvH assay. Lower or higher concentra- 
tions of D-B  cAMP were inactive,  thus  resembling the effects obtained with 
various concentrations  of Poly(A:U)  (see Table I). In the  next  experiment, 
when theophylline, an inhibitor of cyclic nucleotide phosphodiesterase known to 200  THYMUS  HUMORAL  FACTOR  AND  IMMUNE  COMPETENCE 
increase cellular concentrations of cAMP (30), was tested, it was found that it 
also enables spleen cells from NTx mice to respond in the in vitro GvH assay 
(Table III). In light of the above results, it appears that  induction  of compe- 
tence by THF in spleen cells obtained from NTx mice is due to an increase in 
intracellular  levels of cAMP. 
The GvH tests described above were performed vis-a-vis allogeneic antigens 
present in the assay system. However, we have previously shown that THF does 
TABLE II 
Effect of Various  Concentrations of D-B cAMP on the Induction o] In Vitro GvH Response by 
Spleen  Cells of NTx C57BL/6 Mice 
Substance tested  Concn ~g/ml medium)  Incidence of reactive cultures  Culture response 
% 
_  _  0/5  1/8  o/s  6 
THF  20*  4/5  6/8  77 
D-B cAMP  0.0005  0/5  0/8  0 
D-B cAMP  0.001  3/5  6/8  3/5  67 
D-B cAMP  0.005  1/5  1/8  15 
* #g of protein per 1 ml culture medium added at the start of cultures. 
TABLE  III 
The Effect  of Theophylline  on the Induction of In  Vitro GvH Response by Spleen  Cells of 
NTx C57BL/6 Mice 
Incidence of reactive  Culture response  Substance tested  Conch.  (#g/ml medium)  cultures 
% 
_  _  1.  0/5  lO 
THF  20*  3/5  4/5  70 
Theophylline  0.001  4/5  5/5  90 
* #g protein per 1 ml culture. 
not require antigenic stimulation to induce competence since syngeneic prepa- 
rations  of THF restores competence  to  spleen  cells before  their  exposure  to 
antigenic stimulation (8). It was, therefore, of interest to find out whether sub- 
stances that increase intracellular levels of cAMP will also restore immunologi- 
cal competence to lymphoid cells in  the absence of the allogeneic stimulation 
provided by the GvH assay. To test this hypothesis, the in vitro GvH response 
of spleen cells from NTx C57BL/6 mice was assayed after preincubation with 
theophylline. The cells were incubated for 30 rain at 37°C  with  no  addition, 
with THF,  or with theophylline.  After incubation  the  cells were washed and 
tested in the GvH assay. The results are shown in Table IV. It can be seen that 
both THF and theophylline activate spleen cells of NTx mice prior to their expo- 
sure  to  allogeneic antigens.  However the  increase in  intracellular  cAMP  in- AB1LAHAM I.  KOOK AND NATHAN TRAININ  201 
TABLE  IV 
In Vitro GvH Response of Spleen Cells Obtained from NTx C57BL/6 Mice after Preincubation 
with THF or Tkeophylline* 
Concn. ~g/ml of  Substance tested  medium)  Incidence of reactive  cultures  Culture  response 
% 
--  --  o/s  0/5  1/s  7 
THF  205  3/5  3/5  4/5  67 
Theophylline  0.001  4/5  5/5  4/5  87 
* Cells were incubated for 30 min at 37°C in E.M. or E.M. with THF, or with theophylline. 
Mter incubation, the cells were washed in O.C.M. and 1 X  106 live cells tested in the GvH 
assay. 
5 #g protein per 1 ml culture. 
duced by THF, or theophylline, or by incubation of cells with D-B cAMP does 
not provoke by itself a  nonspecific enlargement of spleen fragments in the in 
vitro assay. This is shown in the following experiment: spleen cells from NTx 
C57BL/6  mice  were  incubated  with  THF,  with  theophylline,  or  with  D-B 
cAMP for 30 min. The cells were then washed and exposed to spleen fragments 
obtained from newborn syngeneic instead of allogeneic mice. From the results 
shown in Table V, it can be seen that no induction of in vitro splenomegaly oc- 
curred under such conditions. 
The experiments presented so far suggest that the first event in the induction 
of competence in a noncompetent lymphoid cell population is characterized by 
a rapid rise in intracellular cAMP levels after stimulation of adenyl cyclase ac- 
tivity. To determine whether this is necessary we proceeded to test whether in- 
hibition of activation of adenyl cyclase prevents the cells from acquiring com- 
petence. Since antagonistic agents to THF are yet unknown, we chose to stimu- 
late adenyl cyclase in lymphocytes by PGE2 (31, 32), and to test the effect of its 
antagonist, flufenamic acid.." (33,  footnote 3), on the induction of immune com- 
petence by PGE2. 
The results presented in Table VI show that PGE2 increases by five-fold the 
level of cAMP in thymus cells obtained from C57BL/6 mice. On the other hand, 
flufenamic acid completely inhibits the rise in intracellular cAMP when added 
together with PGE2 to thymus cells suspensions. Flufenamic acid by itself does 
not appear to enhance either synthesis or breakdown  of intracellular  cAMP in 
thymocytes. 
The effect of PGE2 and its antagonist flufenamic acid on the induction of im- 
mune competence in spleen cells obtained from NTx mice was then tested. Cells 
were incubated  with THF,  with  PGE2  with  PGE2,  and  flufenamic acid, or 
3 Zor, V., S. Bauminger, S. A. Lamprecht, Y. Koch, P. Chobsieng, and H. R. Lindner. 
1973. Stimulation of cyclic AMP production in the rat ovary by luteinizing hormone: inde- 
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TABLE V 
The Effect of THF, Theophylline, or D-B cAMP on the Induction  of In Vitro Splenomegaly in 
Spleen Fragments from C57BL/6 Mice by Spleen Cells  from Syngeneic NTx Mice* 
Conch. (/~g/rnl  of  Substance tested  medmm)  Incidence of reactive cultures  Culture response 
% 
--  --  0/5  1/s  i0 
THF  205  1/5  0/5  10 
Theophylline  0.001  0/5  1/5  10 
D-B cAMP  0.001  0/5  0/5  0 
* Cells were incubated in E.M. for 30 min at 37°C with no addition, with THF, with 
theophylline, or with D-B cAMP. After incubation the cells were washed in O.C.M. and 
1 X 106 live cells tested in the assay. 
5 #g protein per i ml culture. 
TABLE VI 
The Effects of PGE2 and of Flufenamic Acid on Intracdlular cAMP  Content of Thymus  Cells 
from C57BL/6 Mice 
Substance tested (concn.) 
cAMP 
pmoles/50  X  I0~ thyrnocytcs* 
Exp. 1  Exp. 2 
--  17  18 
THF (50/~g protein/ml)  30  34 
PGE2 (5 #g/ml)  97  98 
PGE2 (5 #g/ml) +  flufenamic acid (75 #g/ml)  17  13 
Flufenamic acid (75/~g/ml)  15  18 
* 25 X  106 cells/ml were incubated in E.M. for 5 min at 37°C. Reaction initiated by 
addition of test materials. 
with flufenamlc acid only. Control cell suspensions were incubated with no sub- 
stance added to the medium. After 30 min of incubation the cells were washed 
and tested for immune competence in the in vitro GvH assay. The results are 
shown in Table VII. It can again be observed that the noncompetent spleen 
cell population from NTx mice acquired immunological competence following 
preincubation with THF. Similarly, preincubation with PGE2 also induces the 
deficient spleen cell population of NTx mice to react in the GvH assay. However, 
preincubation of these cells with both PGE2 and flufenamic acid abolished the 
induction of immunological competence. To discard the possibility that  flufe- 
namic acid may block the effect of PGE2 by some nonspecific toxic phenomenon, 
immunologically competent normal spleen cells from C57BL/6 mice were pre- 
incubated  under  the  same  conditions with  and without flufenamic acid and 
subsequently tested for immune competence. The results indicate that no im- 
pairment of the immune competence of normal spleen cells was caused by flu- 
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TABLE  VII 
The Induction  o/GvH Response in Spleen  Cells of NTx  C57BL/6 Mice by Incubation  with 
PGE2 and Inhibition  of tke Effect by Flufenamic Acid 
Substance tested (conch.)  Source of spleen  Incidence  of reactive  Culture  cells*  cultures  response 
% 
--  NTx  0/5  0/5  0 
THF (50 pg protein/ml)  NTx  4/5  3/5  70 
PGE2 (5#g/ml)  NTx  5/5  4/5  4/5  87 
PGE2  (5  /zg/ml)  q-  flufenamic acid  NTx  1/5  0/5  1/5  13 
(75/zg/ml) 
Flufenamic acid (75/zg/ml)  NTx  1/5  0/5  10 
--  Intact  4/5  5/5  5/5  93 
Flufenamic acid (75/~g/ml)  Intact  4/5  5/5  5/5  93 
* 25 X  l0  s spleen cells obtained from either NTx or intact mice were incubated with or 
without the substances tested in 1 ml E.M. for 30 rain at 37°C. Mter incubation the cells 
were washed and tested in the GvH assay. 
Thus, induction  of adenyl cyclase and a  rise in cellular levels of cAMP are 
necessary  events  for acquisition  of competence  by the  noncompetent  spleen 
cells of NTx mice. 
DISCUSSION 
The  experiments  presented  here  were  aimed  at  the  understanding  of  the 
mechanism by which THF increases the competence of spleen cells from NTx 
mice. The results indicate that the endowment of competence to these cells by 
THF is mediated via a rapid increase in cellular levels of cAMP. It has been pre- 
viously demonstrated that Poly(A: U) induces competence in spleen cells from 
NTx mice when tested in vitro for response to SRBC or in vivo for homograft 
rejection (20) and to stimulate adenyl cyclase activity in lymphocytes (28). We 
have now shown in addition that Poly(A: U) induces in adequate concentrations 
the capacity of spleen cells from NTx mice to react in an in vitro GvH test. We 
have also  presented  evidence that  D-B  cAMP  and  substances  known  to  in- 
crease cellular cAMP levels in lymphocytes by different mechanisms such as 
PGE2  and  theophylline  induce  competence in  lymphocytes tested  in  the  in 
vitro GvH assay used here. The increase in cellular cAMP is apparently a neces- 
sary requirement for the induction of competence, since it could be shown that 
when the increase in intracellular  cAMP induced  by PGE2 is blocked by its 
antagonistic agent flufenamic acid, PGE2 looses its ability to induce competence 
in spleen cells of NTx mice. Moreover the kinetic data showing the rapid ele- 
vation of cellular cAMP by THF indicate that this event is probably the  first 
in the sequence of events leading to the induction of competence. 
The possibility that THF exerts its effect as a  consequence of contaminating 
amounts  of  Poly(A:U)  or  Poly(A:U)-like  homoribopolymeres was  excluded 
since THF preparations did not loose their activity after degradation by RNase 204  THYMUS  HUMORAL  FACTOR  AND  IMMUNE  COMPETENCE 
(Kook and Trainin, unpublished observations). The preparations also contained 
no detectable amounts of cAMP. 
Previous observations suggest that an active substance is released by the 
reticular epithelial cells  of the thymus medulla (34-36)  and is present in the 
blood in measurable small quantities (37). The present results indicate that in- 
duction of competence by THF involves activation of adenyl cyclase and a rise 
in cellular cAMP levels. We also observed that D-B  cAMP and theophylline 
mimic the effect of THF. Consistent with the postulates established by Suther- 
land to define hormonal action mediated by cAMP (38), our findings permit the 
classification of TFH as a thymus hormone. Hormones which exert their effect 
via cAMP exhibit a dose response curve with a sharp peak in activity and with 
decreased activity at higher dosages (39, 40). In agreement with this, we found 
that the induction of competence in the in vitro GvH reaction is dose dependent 
on cAMP levels. Thus both D-B cAMP and Poly(A: U) exhibit a dose-response 
pattern, where optimal concentrations produce  GvH response which was in- 
hibited by higher concentrations. Similar observations not presented here were 
made in our laboratory for different THF concentrations. The range for induc- 
tion of in vitro GvH response was found to be 20-80/~g protein per ml of THF. 
As regards the target cell population, the data shown indicate that THF ac- 
tivates adenyl  cyclase in  thymus-derived and  not  in  bone  marrow-derived 
spleen lymphocytes. It is interesting to note that Poly(A:U) has also been re- 
ported to exert its enhancing effects on cell mediated immunity, and antibody 
production on thymus-derived cells only and not on bone marrow-derived cells 
or macrophages (21, 25, 41, 42). These observations are in agreement with pre- 
vious findings in our laboratory (9-11) which suggest that THF exerts its im- 
munoenhancing effect on T-cell populations. On the other hand, it has  been' 
reported that 0-negative bone marrow or spleen cells may acquire some phys- 
icochemical properties  of thymus-derived cell  populations  following interac- 
tions with thymus extracts (43-45). 
Previous experiments from this laboratory in which spleen cells  from NTx 
mice were preincubated with THF demonstrated that THF induces compe- 
tence  in  the  noncompetent  spleen  cell  population  before  their  exposure  to 
foreign antigen (8). Moreover, THF itself does not provide antigenic stimulation 
since it has been previously shown that the THF preparations from syngeneic 
source will also induce immune competence in spleen cells from NTx mice (8). 
Likewise, the present results (Table V) demonstrate that GvH response will not 
take place unless cells which were preincubated with THF were subsequently 
exposed to allogeneic antigens. 
In conclusion, it appears that induction of adenyl cyclase and a rise in cellu- 
lar levels of cAMP are early events necessary for acquisition of competence by 
the noncompetent spleen cells  of NTx  mice. This competence is acquired in 
the absence of antigenic stimulation and is induced by THF. ABRAHAM  I.  KOOK AND NATHAN TRAINIl~  205 
:  SITMMARY 
Experiments reported here were performed to understand the mechanism by 
which THF increases the immunocompetence of spleen cells from NTx mice. 
Dibutyryl cAMP or substances which increase intracellular levels of cAMP in 
lymphocytes such as Poly(A:U), theophylline, or PGE2 were shown to mimic 
the effect of THF and confer reactivity in an in vitro GvH response to spleen 
cells from NTx mice. Flufenamic acid, an antagonist to PGE2, was shown to in- 
hibit the induction of competence by this substance. It was found that THF in- 
duces competence by activating membranal adenyl cyclase which leads to a rise 
in intracellular cAMP in thymus-derived cells only. These biochemical changes 
occur before antigenic stimulation and are unrelated to antigenic challenge. 
These findings indicate that THF exerts its effect via cAMP and are in agree- 
ment with the concepts which permit to classify THF as a thymus hormone. 
The authors acknowledge the excellent assistance of Mr. A. Levy. They are grateful  to 
Dr. M. Small for her helpful advice in preparing the manuscript. 
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